Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emovi
Laval, Quebec, Canadaemovi.ca ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company’s flagship product, the KneeKG system for “knee kinesiography,” provides a dynamic 3D assessment of the knee during movement. It enables clinicians to diagnose pathologic patterns more precisely than static imaging and develop focused treatment strategies. The device has been commercialized and adopted in hospitals and academic centers; clinical benefits include improved function, reduced pain/opioid use/recovery time/interventions per patient.
No specific clinical trial results are cited in public sources; however, the technology has demonstrated value through real-world adoption.
- Therapeutic areas
- OtherRheumatology
- Modalities
- DeviceNon-pharmacological therapy (Knee kinesiography)
- Industry
- Physiological Monitoring
02
Partnerships
Not explicitly listed; sales have started in hospitals and academic centers indicating institutional partnerships.
Beyond the preview
Go deeper on Emovi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emovi.